PLX5622 is a highly selective brain penetrant and orally active CSF1R inhibitor ( IC 50 =0.016 μM; K i =5.9 nM). PLX5622 allows for extended and specific microglial cells elimination , preceding and during pathology development. PLX5622 demonstrates desirable PK properties in varies animals . PLX5622 is predominantly administered via ad libitum diets with a dose of 1200 ppm.
Products | Products > Disease Areas > Cancer | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Signaling Pathways > Protein Tyrosine Kinase/RTK | Products > Research Areas > Neurological Disease | Products > Signaling Pathways > c-Fms
感谢您来到爆牛贸易,请为我们留言或者使用以下方式联系我们,我们将尽快给您回复,并为您提供最真诚的服务,谢谢。